Paolo Ghia, MD, PhD, discusses the CAPTIVATE trial in chronic lymphocytic leukemia/small lymphocytic lymphoma, and what ...

Rachel Venable, DVM, MS, DACVIM (Oncology) discussed what primary doctors can do to treat their patients with cancer when ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has accepted the company's supplemental Biologics License ...

This patient had initially been treated with chlorambucil which had been discontinued due to leucopenia, and subsequently with mycophenolate mofetil with sirolimus, which proved inadequate for control ...

Follicular lymphoma is a diverse disease, both biologically and clinically. Patients may present with indolent, asymptomatic disease or more aggressive, symptomatic disease with high tumor burden ...

Small lymphocytic lymphoma (SLL) is a slow-growing cancer of the immune system. It is typically manageable with treatment, but outlook can depend on a few factors. SLL is one type of non-Hodgkin ...

Multiple myeloma is part of the spectrum of diseases ranging from MGUS to plasma cell leukemia, and similar to MGUS, is characterized by proliferation of a plasma cell clone and subsequent ...